After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in bladder cancer
ArriVent takes in $175M from second biotech IPO of the year
No decision yet on Wegovy heart benefits from EU drug regulator
AbbVie invests $223m in Singapore biologics site
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
